{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:30:24Z","timestamp":1773127824980,"version":"3.50.1"},"reference-count":90,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Croatian Ministry of Science and Education","award":["IP7-FDMZ-2022"],"award-info":[{"award-number":["IP7-FDMZ-2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>A MicroRNA (miRNA) is defined as a small molecule of non-coding RNA (ncRNA). Its molecular size is about 20 nucleotides (nt), and it acts on gene expression\u2019s regulation at the post-transcription level through binding to the 3\u2019untranslated regions (UTR), coding sequences, or 5\u2019UTR of the target messenger RNAs (mRNAs), which leads to the suppression or degradation of the mRNA. In recent years, a huge evolution has identified the origin and function of miRNAs, focusing on their important effects in research and clinical applications. For example, microRNAs are key players in HCV infection and have important host cellular factors required for HCV replication and cell growth. Altered expression of miRNAs affects the pathogenicity associated with HCV infection through regulating different signaling pathways that control HCV\/immunity interactions, proliferation, and cell death. On the other hand, circulating miRNAs can be used as novel biomarkers and diagnostic tools for HCV pathogenesis and early therapeutic response. Moreover, microRNAs (miRNA) have been involved in hepatitis B virus (HBV) gene expression and advanced antiviral discovery. They regulate HBV\/HCV replication and pathogenesis with different pathways involving facilitation, inhibition, activation of the immune system (innate and adaptive), and epigenetic modifications. In this short review, we will discuss how microRNAs can be used as prognostic, diagnostic, and therapeutic tools, especially for chronic hepatitis viruses (HBV and HCV), as well as how they could be used as new biomarkers during infection and advanced treatment.<\/jats:p>","DOI":"10.3390\/medicina59010173","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T02:29:55Z","timestamp":1673836195000},"page":"173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection"],"prefix":"10.3390","volume":"59","author":[{"given":"Fayed","family":"Megahed","sequence":"first","affiliation":[{"name":"Nucleic Acid Research Department, Genetic Engineering and Biotechnological Research Institute (GEBRI), City for Scientific Researches and Technological Applications (SRTA-City), Alexandria 21934, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7041-5445","authenticated-orcid":false,"given":"Ashraf","family":"Tabll","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, National Research Centre, Giza 12622, Egypt"},{"name":"Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo 11517, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa","family":"Atta","sequence":"additional","affiliation":[{"name":"Department of Immunology, Theodor Bilharz Research Institute, Cairo 12411, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameera","family":"Ragheb","sequence":"additional","affiliation":[{"name":"Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo 11517, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Smolic","sequence":"additional","affiliation":[{"name":"Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Petrovic","sequence":"additional","affiliation":[{"name":"Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6867-826X","authenticated-orcid":false,"given":"Martina","family":"Smolic","sequence":"additional","affiliation":[{"name":"Faculty of Dental Medicine and Health Osijek, University of Osijek, Crkvena 21, 31000 Osijek, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1261\/rna.2183803","article-title":"A uniform system for microRNA annotation","volume":"9","author":"Ambros","year":"2003","journal-title":"RNA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13130-X","article-title":"Small RNAs: Classification, biogenesis, and function","volume":"19","author":"Kim","year":"2005","journal-title":"Mol. Cells"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2010.03.013","article-title":"Posttranscriptional regulation of microRNA biogenesis in animals","volume":"38","author":"Siomi","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/molecules19056080","article-title":"Issues and prospects of microRNA-based biomarkers in blood and other body fluids","volume":"19","author":"Chevillet","year":"2014","journal-title":"Molecules"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2017.12.011","article-title":"Secretory microRNAs as biomarkers of cancer","volume":"78","author":"Kai","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","article-title":"Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding","volume":"153","author":"Helwak","year":"2013","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/med.20215","article-title":"Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers","volume":"32","author":"Zen","year":"2012","journal-title":"Med. Res. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMcibr1503100","article-title":"Expanding on exosomes and ectosomes in cancer","volume":"372","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1113\/jphysiol.2011.213363","article-title":"Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training","volume":"589","author":"Baggish","year":"2011","journal-title":"J. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/s41598-017-02294-y","article-title":"Time-course responses of circulating microRNAs to three resistance training protocols in healthy young men","volume":"7","author":"Cui","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2014.09.013","article-title":"MicroRNA and cancer\u2014A brief overview","volume":"57","author":"Acunzo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sol\u00e9, C., Molin\u00e9, T., Vidal, M., and Ordi-Ros, J. (2019). Cort\u00e9s-Hern\u00e1ndez, J An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis. Cells, 8.","DOI":"10.3390\/cells8080773"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3892\/or.2017.5600","article-title":"A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1110 cases","volume":"37","author":"Xiong","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.25849","article-title":"Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"ref_24","first-page":"S10","article-title":"RCirculating non-coding RNAs as potential diagnostic biomarkers in liver diseases","volume":"14","author":"Mokhtari","year":"2021","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12072-021-10277-5","article-title":"miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1","volume":"16","author":"Ma","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","article-title":"Circulating microRNAs in hepatitis B virus-infected patients","volume":"18","author":"Ji","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.24441","article-title":"MicroRNAs-372\/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I\/B","volume":"54","author":"Guo","year":"2011","journal-title":"Hepatology"},{"key":"ref_28","first-page":"4511","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/1751-2980.12185","article-title":"Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection","volume":"15","author":"Huang","year":"2014","journal-title":"J. Dig. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","article-title":"Suppression of type I collagen production by microRNA-29b in cultured human stellate cells","volume":"391","author":"Ogawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","article-title":"Suppression of hepatic stellate cell activation by microRNA-29b","volume":"412","author":"Sekiya","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","article-title":"miR-133a mediates TGF-\u03b2-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis","volume":"58","author":"Roderburg","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1755-1536-5-12","article-title":"Induction of microRNA-214-5p in human and rodent liver fibrosis","volume":"5","author":"Iizuka","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","article-title":"MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis","volume":"61","author":"Ogawa","year":"2012","journal-title":"Gut"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2008.080096","article-title":"Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype","volume":"173","author":"Connolly","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations","volume":"47","author":"Ladeiro","year":"2008","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1158\/0008-5472.CAN-10-1001","article-title":"Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2010.09.023","article-title":"Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis","volume":"54","author":"Gao","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.26514","article-title":"Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells","volume":"58","author":"Song","year":"2013","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"ofab108","DOI":"10.1093\/ofid\/ofab108","article-title":"Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection-Related Hepatocellular Carcinoma","volume":"8","author":"Zhao","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection--natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_44","first-page":"238","article-title":"Chronic hepatitis B virus infection: Current and future treatment strategies","volume":"65","author":"Thimme","year":"2022","journal-title":"Gesundh. Gesundh."},{"key":"ref_45","first-page":"10","article-title":"Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line","volume":"122","author":"Liu","year":"2009","journal-title":"Chin. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1007\/s11033-021-06818-8","article-title":"Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection","volume":"48","author":"Shahen","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.compbiolchem.2007.01.005","article-title":"HBV-encoded microRNA candidate and its target","volume":"31","author":"Jin","year":"2007","journal-title":"Comput. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s11033-021-07072-8","article-title":"Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice","volume":"49","author":"Panzarin","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2009.12.043","article-title":"Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2012.12.071","article-title":"MicroRNA-501 promotes HBV replication by targeting HBXIP","volume":"430","author":"Jin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"703205","DOI":"10.3389\/fgene.2021.703205","article-title":"The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1743-422X-8-354","article-title":"Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells","volume":"8","author":"Su","year":"2011","journal-title":"Virol. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"Taganov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: New regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.23660","article-title":"Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2010.08.008","article-title":"Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210","volume":"88","author":"Zhang","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1093\/nar\/gkr067","article-title":"Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen","volume":"39","author":"Potenza","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_59","first-page":"9957440","article-title":"Analysis of Serum MicroRNA-122 Expression at Different Stages of Chronic Hepatitis B Virus Infection","volume":"2021","author":"Liu","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"198336","DOI":"10.1016\/j.virusres.2021.198336","article-title":"microRNA-125a targets MAVS and TRAF6 to modulate interferon signaling and promote HCV infection","volume":"296","author":"Yan","year":"2021","journal-title":"Virus Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e0190321","DOI":"10.1128\/jvi.01903-21","article-title":"MicroRNA 122 Affects both the Initiation and the Maintenance of Hepatitis C Virus Infections","volume":"96","author":"Panigrahi","year":"2022","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nature06205","article-title":"Interferon modulation of cellular microRNAs as an antiviral mechanism","volume":"449","author":"Pedersen","year":"2007","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23401","article-title":"MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins","volume":"51","author":"Hou","year":"2010","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ali, N., Allam, H., Bader, T., May, R., Basalingappa, K.M., Berry, W.L., Chandrakesan, P., Qu, D., Weygant, N., and Bronze, M.S. (2013). Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS ONE, 8.","DOI":"10.1371\/annotation\/fcc840e2-225c-4d71-920d-a1eab7747e19"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3109\/00365520903215305","article-title":"miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells","volume":"44","author":"Wu","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chom.2008.05.013","article-title":"Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome","volume":"4","author":"Jopling","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1073\/pnas.0704894104","article-title":"Cellular cofactors affecting hepatitis C virus infection and replication","volume":"104","author":"Randall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1128\/JVI.00882-12","article-title":"Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A","volume":"86","author":"Shrivastava","year":"2012","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/srep00637","article-title":"Silencing of microRNA-122 enhances interferon-\u03b1 signaling in the liver through regulating SOCS3 promoter methylation","volume":"2","author":"Yoshikawa","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1593\/neo.131362","article-title":"Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis","volume":"15","author":"Zhang","year":"2013","journal-title":"Neoplasia"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sarma, N.J., Tiriveedhi, V., Subramanian, V., Shenoy, S., Crippin, J.S., Chapman, W.C., and Mohanakumar, T. (2012). Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050826"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1440-1746.2010.06512.x","article-title":"Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma","volume":"26","author":"Law","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.26095","article-title":"MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?","volume":"57","author":"Giordano","year":"2013","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.22158","article-title":"MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma","volume":"47","author":"Varnholt","year":"2008","journal-title":"Hepatology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.18632\/oncotarget.28036","article-title":"Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer","volume":"12","author":"Petkevich","year":"2021","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3855\/jidc.12230","article-title":"Role of circulating microRNA-21 and microRNA-215 in the diagnosis of hepatitis C related hepatocellular carcinoma","volume":"15","author":"Abdelkhalek","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"New Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"14043","DOI":"10.1074\/jbc.RA119.007970","article-title":"Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","article-title":"microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01803-8","article-title":"Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3\/miRNA-30b-5p\/MINPP1 axis","volume":"40","author":"Chen","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1038\/srep12921","article-title":"Serum miRNA expression profile as a prognostic biomarker of stage II\/III colorectal adenocarcinoma","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molonc.2014.02.009","article-title":"The validity of circulating microRNAs in oncology: Five years of challenges and contradictions","volume":"8","author":"Jarry","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: Approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jcp.20713","article-title":"MicroRNA: A new player in stem cells","volume":"209","author":"Zhang","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.compbiolchem.2006.08.006","article-title":"Computational identification of microRNAs and their targets","volume":"30","author":"Zhang","year":"2006","journal-title":"Comput. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2007.08.004","article-title":"Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs","volume":"117","author":"Yang","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lefesvre, P., Attema, J., and van Bekkum, D. (2002). A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Mol. Biol., 3.","DOI":"10.1186\/1471-2199-3-12"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:29Z","timestamp":1760119589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010173"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010173","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}